These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30993715)

  • 1. Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2.
    Wu S; Han M; Zhang C
    J Cell Physiol; 2019 Aug; 234(10):19059-19072. PubMed ID: 30993715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.
    Wang AQ; Lv M; Xu YH; Xie PM; Dong YY
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9860-9868. PubMed ID: 33090389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2.
    Dutta M; Das B; Mohapatra D; Behera P; Senapati S; Roychowdhury A
    Life Sci; 2022 Jul; 301():120592. PubMed ID: 35504332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation.
    Huang YX; Nie XG; Li GD; Fan DS; Song LL; Zhang XL
    Int J Oncol; 2018 Dec; 53(6):2615-2626. PubMed ID: 30320366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATAD2 silencing decreases VEGFA secretion through targeting has-miR-520a to inhibit angiogenesis in colorectal cancer.
    Hong S; Chen S; Wang X; Sun D; Yan Z; Tai J; Bi M
    Biochem Cell Biol; 2018 Dec; 96(6):761-768. PubMed ID: 29958090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma.
    Liu H; Cao B; Zhao Y; Liang H; Liu X
    Cancer Biomark; 2018; 22(4):621-629. PubMed ID: 29843209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.
    Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y
    Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).
    Hong S; Bi M; Chen S; Zhao P; Li B; Sun D; Tai J
    Neoplasma; 2016; 63(6):873-879. PubMed ID: 27565325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J; Li Z; Li F
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.
    Che X; Qian Y; Li D
    J Mol Neurosci; 2018 Feb; 64(2):252-261. PubMed ID: 29264763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-140-5p suppresses retinoblastoma cell proliferation, migration, and invasion by targeting CEMIP and CADM3.
    Miao X; Wang Z; Chen B; Chen Y; Wang X; Jiang L; Jiang S; Hao K; Zhang W
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):42-47. PubMed ID: 29808799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
    Bai S; Tian B; Li A; Yao Q; Zhang G; Li F
    Eye (Lond); 2016 Dec; 30(12):1630-1638. PubMed ID: 27518550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells.
    Hong S; Bi M; Yan Z; Sun D; Ling L; Zhao C
    Neoplasma; 2016; 63(6):846-855. PubMed ID: 27565322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.
    Li X; Yang L; Shuai T; Piao T; Wang R
    Biomed Pharmacother; 2016 Aug; 82():247-55. PubMed ID: 27470361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways.
    Zhang M; Li Q; Pan Y; Wang H; Liu G; Yin H
    Oncol Rep; 2018 Apr; 39(4):2040-2050. PubMed ID: 29436689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.